Archive | Biotech RSS feed for this section

The 4 Types of Biotech Stocks: Which Should You Own?

Well, it certainly has not been a dull start for the biotech sector so far in 2017. After a punk year for M&A activity in 2016, we saw three large deals announced across the industry in January. This helped trigger a 10% surge in this area of the market in February. In March, we have […]

Read more

3 Small Biotech Moonshots to Add to Your Portfolio

As the biotech sector heats up more in 2017, small stocks like the three in this article have already turned in some stellar performances. With the entire sector gaining steam, there’s still plenty of upside left. Bret Jensen recommends adding these three stocks to the portfolio.  Sentiment on the biotech sector early in 2017 sure has […]

Read more

3 Biotech Stock Beneficiaries of a Streamlined FDA

With lower approval wait times and decreased regulations on the horizon, long-term investing opportunities in the biotech sector haven’t looked this great in over two years. Take a look at these three stocks in particular as they will reap the most reward from a streamlined FDA.  After an approximate gain of 10% in February, the […]

Read more

3 Triple-Digit Winners in Biotech Revisited

After an especially great start to 2017, these three stocks that Bret Jensen has profiled often on these pages have shot up like rockets and now all have substantial triple-digit gains. Now’s the time to take some gains in these stocks if you followed along on Bret’s earlier recommendations.  The biotech sector has seen a […]

Read more

3 Promising Biotech Rocket Stocks to Add to Your Portfolio

Even if you’ve never owned a biotech stock before, you will find three valuable picks in this article that can be owned with confidence. All three have had very positive news come out recently and have seen their stock prices start to rise. With the sector starting to wake back up, these stocks can run […]

Read more

3 Ways to Profit in the Market’s Most Underrated Sector

After rallying 8% just in February, the market’s worst performing sector last year looks like it could become the market’s best performing sector this year. Bret Jensen shares three ways he’s positioning his portfolio and his investments to make money from the massive turnaround.  The amount of questions I am getting about the biotech sector […]

Read more

3 Themes to Watch in the Market’s Top Turnaround Sector

Finding the best returns of the next twelve months usually starts with searching out the stocks and sectors that did the worst in the last twelve. Here’s what to watch in the market’s best bet for big returns in 2017. After underperforming the overall market substantially for some 18 months, the biotech sector appears to […]

Read more

3 Attractive Growth Stocks with Near-Term Catalysts

The market is off to a much stronger start this year than the bloodbath equities were greeted with to begin 2016. Biotech, after a dismal 18 months of underperformance is no exception. Sentiment on this beaten down part of the market started to improve immediately after the unexpected election result in November. The specter of […]

Read more

5 Growth Stocks with Major Profit Trends to Bank On

If you’re looking for the next big driver of profit growth in the markets, consider investing in these five stocks that Bret Jensen has identified today. All five have catalysts for growth happening right now, so don’t wait and see which stocks Bret’s recommending today. Snapping up this fast-growing software company might be just the […]

Read more

3 Off-the-Radar Biotech Picks with Upside Potential

Bret Jensen shares three small cap biotech stocks that have attractive risk to reward profiles and will fit nicely into an aggressive investor’s portfolio. The biotech sector, after being shellacked in 2016, is off to a much stronger start so far in 2017. This area of the market has posted solid gains in January to […]

Read more